Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.93 USD | -0.21% | +0.34% | +24.57% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.57% | 10.14B | |
+27.22% | 659B | |
+27.68% | 557B | |
-4.25% | 359B | |
+16.59% | 322B | |
+9.85% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Morgan Stanley Adjusts Price Target on Catalent to $160 From $147, Maintains Overweight Rating